Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Services
  • Locations
  • Physicians
  • Patient and Visitor Info
  • Clinical Trials
  • Event Calendar
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Physicians > Kelsey, Christopher R.
Jumbo Large Regular Text:
Print E-mail
Physicians

Christopher R. Kelsey, MD

Related Content

Services

  • Hematologic Malignancies Program
  • Lung Cancer Radiation Therapy

Share

Christopher R. Kelsey, MD

Department / Division
Radiation Oncology / Radiation Onc-Clinical Sup

Address
DUMC 3085
Durham, NC 27710

Appointment Telephone
919-660-2100

Office Telephone
919-668-5213

Fax Telephone
919-668-7345

Training
  • MD, University of Colorado School of Medicine, 2002

Residency
  • Radiation Oncology, Duke University Medical Center, 2007

Clinical Interests
Hodgkin's and non-Hodgkin's lymphoma, multiple myeloma, mycosis fungoides, lung cancer, plural mesothelioma, thymic malignancies

Research Interests
Clinical trials that are currently open include a study of accelerated radiation therapy for locally-advanced thoracic malignancies (non-small cell lung cancer, small cell lung cancer, and inoperable thymic malignancies) in which patients are treated 6 times a week instead of 5 (two treatments on Fridays), using intensity modulated radiation therapy, with the goal of better tumor control with a lower risk of side effects. We also have a study open investigating lower doses of radiation therapy for patients with diffuse large B-cell lymphoma, with the goal of maintaining excellent tumor control but decreasing the risk of long-term side effects of treatment.

I also have an interest in genetic determinants of radiation sensitivity, predictors of local recurrence after surgery for lung cancer, radiation-induced lung injury, and the role of radiation therapy in advanced (stage III-IV) diffuse large B-cell lymphoma and Hodgkin lymphoma.

Industry Relationships and Collaborations (What's this?)

This physician has no reported relationships with industry.

Representative Publications
Dorth JA, Chino JP, Prosnitz LR, Diehl LF, Beaven AW, Coleman RE, Kelsey CR. The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans.  Ann Oncol.  2010 Aug 9. (2010) Abstract

Kelsey CR, Mukundan S Jr, Wang Z, Hahn CA, Soher BJ, Kirkpatrick JP. Assessing neurotoxicity from the low-dose radiation component of radiosurgery using magnetic resonance spectroscopy.  Neuro Oncol.  2010 Feb;12(2):145-52. (2010) Abstract

Higgins K, Chino JP, Marks LB, Ready N, D'Amico TA, Clough RW, Kelsey CR. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.  Int J Radiat Oncol Biol Phys.  2009 Dec 1;75(5):1462-7. (2009) Abstract

Kelsey CR, Marks LB, Hollis D, Hubbs JL, Ready NE, D'Amico TA, Boyd JA. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients.  Cancer.  2009 Nov 15;115(22):5218-27. (2009) Abstract

Kelsey CR, Kahn D, Hollis DR, Miller KL, Zhou SM, Clough RW, Marks LB. Radiation-induced narrowing of the tracheobronchial tree: an in-depth analysis.  Lung Cancer.  2006 Apr;52(1):111-6. (2006) Abstract

Kelsey CR, Light KL, Marks LB. Patterns of failure after resection of non-small-cell lung cancer: implications for postoperative radiation therapy volumes.  Int J Radiat Oncol Biol Phys.  2006 Jul 15;65(4):1097-105. (2006) Abstract

Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En Español | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2012 Duke University Health System

About This Page

Updated: July 2, 2007
Published: July 2, 2007
URL: http://www.dukehealth.org/physicians/christopher_r_kelsey